SecBot SecBot
COURT-RULING ·Filed Mar 30, 2026

BIIB

Biogen
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago CourtCourt Ruling · ecf.ilnd.uscourts.gov
Court ruling (district)
Actionable Insight • Neutral

Monitor for release of actual court opinion or docket update; current filing appears to be a system-generated placeholder with no legal substance

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$186.93
T+0 close · Mar 30, 2026 · via day close
Latest settled
+6.77%
T+60 · $199.59
Vs SPY
−9.25%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 30 $186.93entry
  2. T+1 · 8mo ago −2.36%α −5.25% · $182.52
  3. T+5 · 7mo ago −6.05%α −10.35% · $175.61
  4. T+20 · 7mo ago −2.03%α −14.63% · $183.13
  5. T+60 · 5mo ago +6.77%α −9.25% · $199.59
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable

Court Ruling Details

Court
United States District Court for the Northern District of Illinois
Court Level
District
Case Type
contract
Ruling Type
other
Outcome
NULL
Precedent Risk
LOW

Key Facts

  • Case: Walgreen Co. et al v. Biogen, Inc. (1:25-cv-11680), filed in the United States District Court for the Northern District of Illinois
  • Filed on 2026-03-30, status is unknown
  • No substantive opinion or ruling text available, only a procedural placeholder or login redirect was provided

Financial Impact

No financial impact can be assessed due to lack of content

Risk Factors

  • Potential for material ruling once full opinion is released
  • Uncertainty due to lack of accessible ruling details

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
47% bullish (43 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-3qxgjdmg-BIIB

Track record

34 reports on BIIB

Performance horizon

10 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jul 13, 2026 report. 16 of 17 went positive at some point.

Filters
  1. Nov 12, 20264d ago Press Release Neutral 3/10 Entry $253.40 Now $251.65 −0.69% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $253.25 Now $251.65 −0.63% settles Feb 8
  3. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $254.87 Now $251.65 −1.26% settles Feb 5
  4. Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
  5. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
  6. Oct 19, 202628d ago Press Release Neutral 4/10 Entry $233.48 Now $251.65 +7.78% settles Jan 14
  7. Oct 12, 20265w ago ANALYST-UPGRADE Bullish 6/10 Entry $229.41 Now $251.65 +9.69% settles Jan 7
  8. Oct 2, 20266w ago Press Release Bullish 6/10 Entry $219.88 Now $251.65 +14.45% settles Dec 29
  9. Sep 17, 20268w ago Press Release Bullish 5/10 Entry $215.50 Now $251.65 +16.77% settles Dec 14
  10. Sep 3, 202610w ago Press Release Neutral 4/10 Entry $220.83 Now $251.65 +13.96% settles Dec 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (11h 21m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · ecf.ilnd.uscourts.gov Report published Mar 30, 2026